Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 602, Issue 1-2, 2006, Pages 43-53

  Ingraham, Susan E ^a   Lynch, Roy A ^a   Surti, Urvashi ^b   Rutter, Joni L ^c   Buckler, Alan J ^d   Khan, Sohaib A ^e   Menon, Anil G ^a   Lepont, Pierig ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Chromosomal translocation; Embedded transcripts; HMGA2; Non coding RNA; Novel laminin receptor; Uterine leiomyoma

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; LAMININ RECEPTOR; RNA;

ARTICLE; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TRANSLOCATION; GENETIC REGULATION; GENETIC TRAIT; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; UTERUS MYOMA;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 14; EXPRESSED SEQUENCE TAGS; FEMALE; HMGA2 PROTEIN; HUMANS; LEIOMYOMA; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MYOMETRIUM; PROMOTER REGIONS (GENETICS); RECEPTORS, LAMININ; TRANSLOCATION, GENETIC; UTERINE NEOPLASMS;

EID: 33750615247     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.07.007     Document Type: Article

References (46)

1. Cramer S.F., and Patel A. The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 94 (1990) 435-438
2. Greenberg M.D., and Kazamel T.I. Medical and socioeconomic impact of uterine fibroids. Obstet. Gynecol. Clin. North Am. 22 (1995) 625-636
3. Buttram Jr. V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil. Steril. 36 (1981) 433-445
4. Mitelman F. Catalog of Chromosome Aberrations in Cancer (1994), Wiley-Liss, New York
5. Sreekantaiah C., Ladanyi M., Rodriguez E., and Chaganti R.S. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am. J. Pathol. 144 (1994) 1121-1134
6. Sandberg A.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet. Cytogenet. 158 (2005) 1-26
7. Rein M.S., Powell W.L., Walters F.C., Weremowicz S., Cantor R.M., Barbieri R.L., and Morton C.C. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol. Hum. Reprod. 4 (1998) 83-86
8. Turc-Carel C., Dal Cin P., Boghosian L., Terk-Zakarian J., and Sandberg A.A. Consistent breakpoints in region 14q22-q24 in uterine leiomyoma. Cancer Genet. Cytogenet. 32 (1988) 25-31
9. Heim S., Nilbert M., Vanni R., Floderus U.M., Mandahl N., Liedgren S., Lecca U., and Mitelman F. A specific translocation, t(12;14)(q14-15;q23-24), characterizes a subgroup of uterine leiomyomas. Cancer Genet. Cytogenet. 32 (1988) 13-17
10. Meloni A.M., Surti U., Contento A.M., Davare J., and Sandberg A.A. Uterine leiomyomas: cytogenetic and histologic profile. Obstet. Gynecol. 80 (1992) 209-217
11. Schoenmakers E.F., Mols R., Wanschura S., Kools P.F., Geurts J.M., Bartnitzke S., Bullerdiek J., van den Berghe H., and Van de Ven W.J. Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chromosomes Cancer 11 (1994) 106-118
12. Van de Ven W.J., Schoenmakers E.F., Wanschura S., Kazmierczak B., Kools P.F., Geurts J.M., Bartnitzke S., Van den Berghe H., and Bullerdiek J. Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer 12 (1995) 296-303
13. Lynch R.A., Piper M., Bankier A., Bhugra B., Surti U., Liu J., Buckler A., Dear P.H., and Menon A.G. Genomic and functional map of the chromosome 14 t(12;14) breakpoint cluster region in uterine leiomyoma. Genomics 52 (1998) 17-26
14. Schoenmakers E.F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., and Van de Ven W.J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 10 (1995) 436-444
15. Ashar H.R., Fejzo M.S., Tkachenko A., Zhou X., Fletcher J.A., Weremowicz S., Morton C.C., and Chada K. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82 (1995) 57-65
16. Rogalla P., Drechsler K., Frey G., Hennig Y., Helmke B., Bonk U., and Bullerdiek J. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am. J. Pathol. 149 (1996) 775-779
17. Kazmierczak B., Pohnke Y., and Bullerdiek J. Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 38 (1996) 223-226
18. Gattas G.J., Quade B.J., Nowak R.A., and Morton C.C. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 25 (1999) 316-322
19. Klotzbucher M., Wasserfall A., and Fuhrmann U. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas. Am. J. Pathol. 155 (1999) 1535-1542
20. Miyazawa J., Mitoro A., Kawashiri S., Chada K.K., and Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res. 64 (2004) 2024-2029
21. Odero M.D., Grand F.H., Iqbal S., Ross F., Roman J.P., Vizmanos J.L., Andrieux J., Lai J.L., Calasanz M.J., and Cross N.C. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 19 (2005) 245-252
22. Patel U.A., Bandiera A., Manfioletti G., Giancotti V., Chau K.Y., and Crane-Robinson C. Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochem. Biophys. Res. Commun. 201 (1994) 63-70
23. Zhou X., Benson K.F., Ashar H.R., and Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376 (1995) 771-774
24. Schoenberg Fejzo M., Ashar H.R., Krauter K.S., Powell W.L., Rein M.S., Weremowicz S., Yoon S.J., Kucherlapati R.S., Chada K., and Morton C.C. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 17 (1996) 1-6
25. Schoenmakers E.F., Huysmans C., and Van de Ven W.J. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 59 (1999) 19-23
26. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., and Marra M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99 (2002) 16899-16903
27. Buckler A.J., Chang D.D., Graw S.L., Brook J.D., Haber D.A., Sharp P.A., and Housman D.E. Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc. Natl. Acad. Sci. USA 88 (1991) 4005-4009
28. Altschul S., Madden T., Schaffer A., Zhang J., Zhang Z., Miller W., and Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997) 3389-3402
29. Fickett J.W. Recognition of protein coding regions in DNA sequences. Nucleic Acids Res. 10 (1982) 5303-5318
30. Mount S.M. A catalogue of splice junction sequences. Nucleic Acids Res. 10 (1982) 459-472
31. Kurose K., Mine N., Iida A., Nagai H., Harada H., Araki T., and Emi M. Three aberrant splicing variants of the HMGIC gene transcribed in uterine leiomyomas. Genes Chromosomes Cancer 30 (2001) 212-217
32. Hauke S., Rippe V., and Bullerdiek J. Chromosomal rearrangements leading to abnormal splicing within intron 4 of HMGIC?. Genes Chromosomes Cancer 30 (2001) 302-304
33. Mine N., Kurose K., Nagai H., Doi D., Ota Y., Yoneyama K., Konishi H., Araki T., and Emi M. Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas. J. Hum. Genet. 46 (2001) 408-412
34. Sanchez-Garcia I. Consequences of chromosomal abnormalities in tumor development. Ann. Rev. Genet. 31 (1997) 429-453
35. Arlotta P., Tai A.K., Manfioletti G., Clifford C., Jay G., and Ono S.J. Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J. Biol. Chem. 275 (2000) 14394-14400
36. Kazmierczak B., Bullerdiek J., Pham K.H., Bartnitzke S., and Wiesner H. Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet. Cytogenet. 103 (1998) 175-177
37. Hauke S., Flohr A.M., Rogalla P., and Bullerdiek J. Sequencing of intron 3 of HMGA2 uncovers the existence of a novel exon. Genes Chromosomes Cancer 34 (2002) 17-23
38. Mendell J.T., and Dietz H.C. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107 (2001) 411-414
39. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., Taraseviciene L., Nordeen S.K., Allegretto E.A., and Edwards D.P. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell Biol. 18 (1998) 4471-4487
40. Eddy S.R. Noncoding RNA genes. Curr. Opin. Genet. Dev. 9 (1999) 695-699
41. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2 (2001) 986-991
42. Erdmann V.A., Szymanski M., Hochberg A., de Groot N., and Barciszewski J. Collection of mRNA-like non-coding RNAs. Nucleic Acids Res. 27 (1999) 192-195
43. Mattick J.S. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 25 (2003) 930-939
44. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., Tsai M.J., and O'Malley B.W. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97 (1999) 17-27
45. Lanz R.B., Razani B., Goldberg A.D., and O'Malley B.W. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). PNAS 99 (2002) 16081-16086
46. Mattick J.S. RNA regulation: a new genetics?. Nat. Rev. Genet. 5 (2004) 316-323